United States · Series C startup
4 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$83Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Novartis Venture Fund
Venture Investors
Kearny Venture Partners
Triathlon Medical Venture Partners
Athenian Venture PartnersReported by akebia.comSEC filing: $14M sold, first sale Apr 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Akebia Therapeutics's investors include Novartis Venture Fund, Triathlon Medical Venture Partners, Athenian Venture Partners, Sigvion Capital and Venture Investors, and 6 more on record.
Akebia Therapeutics has raised $83M across 4 rounds since 2009.
Akebia Therapeutics's most recent round was a Series C of $41M in Jun 2013.
Its most recent round, $41M in Jun 2013, is also its largest on record.
Akebia Therapeutics's first round on record, in Sept 2009, was backed by Novartis Venture Fund, Triathlon Medical Venture Partners and Athenian Venture Partners and 2 others.
Akebia Therapeutics's latest named round is a Series C, in Jun 2013.
Akebia Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·